Skip to content

comparing the effectiveness of herbal Unani Medicines and a Modern Drug (Ormeloxifene) in Treating Breast Lump.

Therapeutic Evaluation of Unani compound Drugs versus Ormeloxifene in Case of Fibroadenosis and Fibroadenoma A comparative Study - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078866
Enrollment
30
Registered
2025-01-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: D249- Benign neoplasm of unspecified breast

Interventions

Intervention1: 1.Itrifal ghadudi 2. Nuskha zimad: 1. 10gm BD Orally for 3months 2. Topical application Of Zimad on affected breast at night for 3 months Control Intervention1: Tab Ormeloxifene 30mg:

Sponsors

State Takmeel ut Tib College and Hosipital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All female patients with pain and breast nodularity. All the diagnosed cases of fibro adenosis and fibroadenoma. If lump size is less than or equal to 5cm 18 to 40 years of age group (reproductive age)

Exclusion criteria

Exclusion criteria: Age less than 18 to more than 40 years. If lump size more than 5cm Pregnant, lactating women. If patient is on any OCP. Patients with PCOD or Cervico uterine disease. Breast malignancy or family history of breast malignancy. If patient is diabetic or hypertensive Those patients who are not complying with treatment regime.

Design outcomes

Primary

MeasureTime frame
pain subsided lump size is reduced Timepoint: at 15th,30th,45th,60th,75th,90th days

Secondary

MeasureTime frame
To treat the fibroadenosis and fibroadenomaTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Iram Naseer

State Takmeel Ut Tib College and Hospital

baigrakhshi12@gmail.com7068439403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026